3630 results for «220»
3630 results
Which device for which patient: DES, BRS or DCB?
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.
High-risk PCI in acute coronary syndrome
22 May 2025 – From EuroPCR 2025
Explore high-risk PCI strategies in acute coronary syndrome patients who are unsuitable for surgery. This session presents insights on Killip class influence, haemodynamic support with micro-axial flow pumps, disease progression patterns in complicated STEMI, and the prognostic value of QFR-guided functional SYNTAX scores in ACS management.
TAVI coronary access
22 May 2025 – From EuroPCR 2025
Gain expertise in managing coronary access challenges in TAVI patients. This session discusses when and how to treat coronary lesions in TAVI candidates, strategies to facilitate coronary approach post-TAVI, and long-term outcomes with practical tips through illustrative cases including primary PCI after CoreValve implantation and valve-in-valve...
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
When angina cannot be cured with stents: what are the remaining options
22 May 2025 – From EuroPCR 2025
Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.
TAVI in women
22 May 2025 – From EuroPCR 2025
Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.
TAVI - Outcomes predictors
22 May 2025 – From EuroPCR 2025
Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
Retrograde removal of the broken sheath
22 May 2025 – From EuroPCR 2025
This session addresses complex complications during vascular access with a focus on retrograde removal of broken sheaths. Learn to recognize critical signs, manage rare but severe complications including broken guidewires in the radial artery, and explore innovative off-label solutions for challenging scenarios.
Integrating CT coronary angiography into your PCI practice
22 May 2025 – From EuroPCR 2025
Integrate CT coronary angiography into your PCI practice to enhance procedural planning and outcomes. This session covers practical CT-based approaches for guiding catheter selection, lesion analysis, and stenting strategy. Learn how to leverage CT imaging to anticipate plaque preparation needs in calcified lesions and optimize catheterization...
Procedural aspects of DCB PCI
22 May 2025 – From EuroPCR 2025
Delve into procedural aspects of drug-coated balloon (DCB) PCI with a focus on lesion preparation, antiplatelet therapy, and outcomes in real-world settings. This session reviews the impact of pre-dilatation balloons on de novo lesions, compares ticagrelor versus clopidogrel post-PCI with drug-eluting balloons, and discusses streamlined revascularization...
Advancing knowledge and innovations in peripheral interventions
22 May 2025 – From EuroPCR 2025
Expand your expertise in peripheral interventions with a focus on recent innovations and clinical insights. This session covers pre-clinical results of a novel Hybrid Drug-Eluting Stent for below-the-knee arteries, the prognostic impact of proteinuria in LEAD patients with chronic kidney disease, beta-blocker therapy effects post-frozen elephant...
LAA closure in challenging scenarios
22 May 2025 – From EuroPCR 2025
This session addresses the complexities of left atrial appendage (LAA) closure in challenging anatomical and clinical scenarios. Learn from compelling cases including management of incomplete surgical LAA ligation, closure of large and complex peridevice leaks, and navigating difficult anatomy in elderly patients. Emphasizing innovative techniques and...
Anatomy, physiology and clinical judgment: insights from contemporary strategies to guide PCI
22 May 2025 – From EuroPCR 2025
Discover contemporary strategies integrating anatomy, physiology, and clinical judgment to guide percutaneous coronary intervention (PCI). This session explores the impact of stress cardiovascular magnetic resonance in primary prevention, viability-guided PCI, and physiology-based decision-making including quantitative flow ratio (QFR). Learn about identifying patients at risk for major...
DCB in STEMI : why, when and how ?
22 May 2025 – From EuroPCR 2025
Explore the evolving role of drug-coated balloons (DCB) in the management of STEMI patients. This session covers practical approaches including primary PCI with DEB, unconventional solutions in urgent scenarios, and personalized treatment strategies especially in very young patients. Learn how DCB technology intersects with complex lesion...
Acute complications during distal left main PCI - Part 1
22 May 2025 – From EuroPCR 2025
Navigate the challenges of acute complications during distal left main PCI with expert guidance. This session discusses troubleshooting techniques for stuck IVUS catheters, stepwise ostial LAD stenting, OCT applications when crush and kiss techniques fail, management of lost stents in heavily calcified bifurcations, and responses to...
Coronary complications: perforation and dissection
22 May 2025 – From EuroPCR 2025
Examine the unpredictable nature of coronary complications such as perforation and dissection during PCI. This session presents real-world cases illustrating sequential complications, their management challenges, and strategies to simplify complex scenarios. Understand how to anticipate, recognize, and effectively respond to these critical incidents to improve procedural...
LV support for very high risk PCI of calficied lesions
22 May 2025 – From EuroPCR 2025
Discover the role of left ventricular (LV) support in performing very high-risk PCI on heavily calcified lesions. This session highlights techniques for navigating complex calcified coronary anatomies using Impella support, strategies for metal casing reshaping, and management of acute MI and cardiac arrest scenarios. Explore alternative...
All you need to know on aorto iliac disease during TAVI: from access to complications management
22 May 2025 – From EuroPCR 2025
Gain expertise in managing aorto-iliac disease during TAVI procedures, from access planning to complication management. This session covers key imaging techniques, decision-making regarding stenting and lesion modification, approaches to access-related complications, and criteria for involving vascular surgeons, ensuring procedural safety and success.
